Overview
Sponsor-declared trial summary
Phase
Human pharmacology (Phase I) - Other
Status
Authorised, recruitment pending
Participants planned
136
Countries
3
Sites
8
Parkinson's Disease
Key facts
- Sponsor
- Mission Therapeutics Limited
- Participant type
- Patients
- Age range
- 18-64 years, 65+ years
- Gender
- Male and Female
- Therapeutic area
- Diseases [C] - Nervous System Diseases [C10]
- Decision date (initial)
- 2026-05-18
- Transition trial
- No
- Low-intervention
- No
- Rare-disease indication
- No
- Vulnerable population
- Yes
External identifiers
- EU CT number
- 2024-517310-15-00
- ISRCTN
- ISRCTN20898392
Trial design
CTIS Part I — objectives, methods, condition coding
Conditions and MedDRA coding
Parkinson's Disease
| Version | Level | Code | Term | System organ class |
|---|---|---|---|---|
| 20.0 | PT | 10061536 | Parkinson's disease | 100000004852 |
Sponsors and contacts
Sponsor organisations, regulatory contacts, third parties
Mission Therapeutics Limited
- Sponsor organisation
- Mission Therapeutics Limited
- Address
- Babraham Hall, Babraham Babraham
- City
- Cambridge
- Postcode
- CB22 3AT
- Country
- United Kingdom
Scientific contact point
- Organisation
- Mission Therapeutics Limited
- Contact name
- Chief Development Officer
Public contact point
- Organisation
- Mission Therapeutics Limited
- Contact name
- Chief Development Officer
Locations
3 EU/EEA countries · 8 investigational sites
By country
| Country | MS status | Planned subjects | Sites |
|---|---|---|---|
| France | Authorised, recruitment pending | 6 | 4 |
| Germany | Authorised, recruitment pending | 6 | 3 |
| Netherlands | Authorised, recruitment pending | 6 | 1 |
| Rest of world
United Kingdom, Australia
|
— | 118 | — |
Investigational sites
Assistance Publique Hopitaux De Paris
Neurology CEC Neurosciences, 47 Boulevard De L Hopital, 75651, Paris Cedex 13
Hospices Civils De Lyon
Hopital neurologique Pierre Wertheimer/Neurologie C, 59 Boulevard Pinel, 69500, Bron
Centre Hospitalier Universitaire De Lille
Neuropharmacologie, Boulevard Du Professeur Jules Leclercq, 59000, Lille
Centre Hospitalier Universitaire De Toulouse
Pharmacologie Cliniqu, 2 Rue Viguerie, 31300, Toulouse
Technische Universitaet Dresden
Klinik und Poliklinik fUr Neurologie, Fetscherstrasse 74, Johannstadt-Nord, Dresden
LMU Klinikum Muenchen AöR
Neurology dep., Marchioninistrasse 15, Hadern, Munich
Universitaetsklinikum Duesseldorf AöR
Neurology dep., Moorenstrasse 5, Bilk, Duesseldorf
Centre for Human Drug Research
Neurology dep., Zernikedreef 8, 2333 CL, Leiden
Application history
1 submissions — initial application plus substantial / non-substantial modifications
| # | Type | Code | Submitted | Reference MS | Conclusion | Decision date |
|---|---|---|---|---|---|---|
| 1 | INITIAL | IN | 2026-01-28 | Germany | Acceptable 2026-05-18
|
2026-05-18 |